勤恳纸鹤
Lv41
480 积分
2025-01-08 加入
-
Tolebrutinib in Nonrelapsing Secondary Progressive Multiple Sclerosis
4小时前
待确认
-
Ziftomenib in relapsed or refractory acute myeloid leukaemia (KOMET-001): a multicentre, open-label, multi-cohort, phase 1 trial
1个月前
已完结
-
Zongertinib in Previously Treated HER2 -Mutant Non–Small-Cell Lung Cancer
1个月前
已完结
-
Discovery of ACT‐1002‐4271 as a Dual EP2/EP4 Antagonist with In Vivo Anti‐Tumor Efficacy
1个月前
已完结
-
Insights into the function and regulation of the calcium-activated chloride channel TMEM16A
2个月前
已完结
-
ANOCTAMIN PHARMACOLOGY
2个月前
已完结
-
WS05.02 A Phase-1 multiple ascending dose healthy volunteer study to evaluate the safety, tolerability, and pharmacokinetics of GDC-6988, a dry powder formulation of a selective inhaled potentiator of TMEM16A
2个月前
已完结
-
TMEM16A (ANO1) as a therapeutic target in cystic fibrosis
2个月前
已完结
-
Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
2个月前
已完结
-
The GLOBOCAN 2022 cancer estimates: Data sources, methods, and a snapshot of the cancer burden worldwide
2个月前
已完结